Lotus Pharm vs DIVA Laboratories: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and DIVA Laboratories (4153) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ DIVA Laboratories

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYDIVA LaboratoriesYoY
Oct 2026NT$2.13 billion-22.5%NT$85.7 million+41.7%
Sep 2026NT$2.77 billion+128.0%NT$85.7 million+38.2%
Aug 2026NT$2.11 billion+81.7%NT$79.6 million+11.8%
Jul 2026NT$2.49 billion+3.9%NT$83.1 million+30.2%
Jun 2026NT$3.4 billion+225.5%NT$95.2 million+40.2%
May 2026NT$2.32 billion+105.8%NT$75.7 million-4.0%
Apr 2026NT$3.09 billion+19.9%NT$74.1 million-16.0%
Mar 2026NT$4.35 billion+173.6%NT$89.3 million+14.6%
Feb 2026NT$2.24 billion+131.5%NT$64.3 million-12.9%
Jan 2026NT$2.05 billion-5.5%NT$69.3 million+25.2%
Dec 2025NT$2.44 billion+66.9%NT$97 million+14.6%
Nov 2025NT$1.06 billion-0.2%NT$72.2 million+0.6%
Oct 2025NT$2.75 billion+46.0%NT$60.5 million-9.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16